GPhC may look at overprescribing risk from IP contractors ‘in future’
The GPhC has said that regulating overprescribing risks is a “developing area”, amid concerns about IP contractor conflicts of interest at this year’s Pharmacy Show.
The General Pharmaceutical Council (GPhC) may look at overprescribing by independent prescriber (IP) pharmacy contractors “in the future”, its deputy regional director David Clark said